Zecdarasib hydrochloride dihydrate is a Kirsten rat sarcoma virus oncogene homolog ( KRAS ) inhibitor with antitumor activity. Zecdarasib hydrochloride dihydrate can be used in tumor-related research [1].
References:
[1]. World Health Organization. International Nonproprietary Names for Pharmaceutical Substances (INN) — Proposed INN: List 135. WHO Drug Information. 2026; 40(2).
References:
[1]. World Health Organization. International Nonproprietary Names for Pharmaceutical Substances (INN) — Proposed INN: List 135. WHO Drug Information. 2026; 40(2).
















